» Articles » PMID: 26017679

Prevalence of Nonalcoholic Fatty Liver Disease and Economy

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2015 May 29
PMID 26017679
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is a growing health issue around the world.

Aim: This study is to investigate whether adult prevalence of NAFLD correlates with national economic status.

Methods: Literature search on PubMed database was conducted to identify eligible records fully published before September 2014. Gross national income (GNI) per capita was chosen to evaluate national economic status. Pearson coefficient, linear regression, and unpaired t test were performed in the statistical analyses.

Results: Twenty-one population-based surveys (seven in East Asia, five in South Asia, three in Middle East, and six in Europe) were included. The pooled prevalence of NAFLD was 24.24%, and the global prevalence was positively correlated with GNI per capita (r = 0.4782, P = 0.0283). Europe witnessed a higher prevalence (28.04%) than Middle East (12.95%, P = 0.0092) and East Asia (19.24%, P = 0.0083). Male presented a higher prevalence than female (P = 0.019), especially in Europe (P = 0.0132) and in Caucasians (P = 0.0383). Furthermore, male prevalence and rural prevalence individually were correlated with economic status (r = 0.5725, P = 0.0257 and r = 0.7389, P = 0.0060). Lastly, the urban (23.93%) witnessed a higher prevalence than the rural or the urban + rural (12.65%, P = 0.0141) in the countries of GNI per capita <$10,000.

Conclusions: This study suggested that countries with higher economic status tend to present a higher prevalence of NAFLD. It is believed to provide a distinctive epidemiologic perspective to global situation of NAFLD.

Citing Articles

Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review.

Miller K, Geyer B, Alexopoulos A, Moylan C, Pagidipati N Dig Dis Sci. 2024; 70(1):154-167.

PMID: 39560808 DOI: 10.1007/s10620-024-08722-0.


High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease.

Hu J, Du Y, Zhou Y, Wang H Sci Rep. 2024; 14(1):19541.

PMID: 39174636 PMC: 11341865. DOI: 10.1038/s41598-024-70645-7.


Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis.

Zhou Q, Hu H, Hu L, Liu S, Chen J, Tong S J Glob Health. 2024; 14:04060.

PMID: 38665062 PMC: 11046257. DOI: 10.7189/jogh.14.04060.


L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999-2004.

Zhang Z, Wang H, Chen M, Chen Y BMC Endocr Disord. 2024; 24(1):35.

PMID: 38468235 PMC: 10926622. DOI: 10.1186/s12902-024-01568-7.


Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.

Kannan S, Nelliyanil M, Mendagudli R, Rajeshwari S, Kona C, Kundapur R J Educ Health Promot. 2024; 12:435.

PMID: 38464628 PMC: 10920698. DOI: 10.4103/jehp.jehp_208_23.


References
1.
Loomba R, Sanyal A . The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013; 10(11):686-90. DOI: 10.1038/nrgastro.2013.171. View

2.
Dassanayake A, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva A . Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009; 24(7):1284-8. DOI: 10.1111/j.1440-1746.2009.05831.x. View

3.
Wagenknecht L, Scherzinger A, Stamm E, Hanley A, Norris J, Chen Y . Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring). 2009; 17(6):1240-6. PMC: 2709735. DOI: 10.1038/oby.2009.4. View

4.
Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni C . Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009; 84(1):84-91. DOI: 10.1016/j.diabres.2008.11.039. View

5.
Caballeria L, Pera G, Rodriguez L, Auladell M, Bernad J, Canut S . Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. Eur J Gastroenterol Hepatol. 2012; 24(9):1007-11. DOI: 10.1097/MEG.0b013e328355b87f. View